Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy s unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.
Kronox Lab Sciences IPO | The IPO comprises solely an offer-for-sale of 95.7 lakh equity shares with no fresh issue component. Therefore, the entire issue proceeds will go to the selling shareholders.
The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares